Orthobiologics Market by Product, Application, and End User - Global Industry Analysis and Forecast to 2025

2018-05-30 / 3800.00 / Pharma & Healthcare / 116 Pages

Description

Industry Trend Analysis

The orthobiologics market is expected to be around $10 billion by 2025. The market is primarily driven by factors such as increasing number of orthopedic surgical procedures performed worldwide due to rising incidence of accidents and sports related injuries. Increasing prevalence of geriatric population around the world is another key factor contributing to the market growth. According to the 2015 World Aging Population report by the United Nations (UN), between 2015 and 2030, the global population aged 60 years and over is expected to grow by 56% from 901 million to 1.4 billion. This number is projected to further rise up to 2.1 billion by 2050. As geriatric people are more susceptible to orthopedic and spinal disorders, such high prevalence will largely contribute to the growth of orthobiologics market during the forecast period. However, factors such as high cost of the procedures and stringent regulatory approval processes can hinder the growth of orthobiologics market during the forecast period.

Product Outlook and Trend Analysis

Viscosupplementation segment dominated the global orthobiologics market in 2016 owing to high adoption of these products for diseases such as hip degenerative joint disease and osteoarthritis. The growth of this market can be further attributed to growing popularity of knee treatments along with the ability of viscosupplementation to act as an effective pain killer as compared to others. Synthetic bone substitutes segment along with stem cell based products is expected to witness significant growth during the forecast period as a result of their reduced cost and associated benefits such as eliminated risk of disease transmission and quick recovery.

Application Outlook and Trend Analysis

Spinal fusion segment accounted for the major share of the overall market in 2016 as the therapy delivers high bone stability along with rapid healing of the bones thus facilitating quick recovery for long-term spinal disorders. In spinal fusion, the rapid stimulation of cells initiates effective bone formation. Moreover, the therapy results in reduced duration of hospital stay which is a key contributing factor to the growth of this market.

End User Outlook and Trend Analysis

Hospitals segment held a major share of the market in 2016 owing to widespread adoption of orthobiological products for various reconstructive surgeries. Furthermore, easy availability of orthobiologics in hospitals and increased emphasis on specialized patient care are expected to boost the growth of the market during the forecast period.

Regional Outlook and Trend Analysis

North America dominated the orthobiologics market in 2016 due to the abundant presence of prominent players in orthobiologics market in the region along with favorable reimbursement policies for fusion enhancement products and soft tissue healing. The Asia-Pacific orthobiologics market is expected to grow at the fastest rate over the forecast period owing to increasing healthcare expenditure in emerging countries along with rising disposable income of the people.

Competitive Insights

The major players in the orthobiologics market focus on new product development strategy to secure a competitive advantage over others. Moreover, they are involved in strategic collaborations, mergers and acquisitions to enhance their presence across different regional markets. For instance, in March 2016, Zimmer Biomet Holdings, Inc. secured an exclusive global distribution agreement with CelgenTek Innovations Corporation for its N-Force Fixation System and CelgenTek's iN3 cement. The agreement enabled CelgenTek to enhance its reach benefiting from Zimmer Biomet’s commercial capabilities.

Some of the key players operating in the orthobiologics market are, Bone Biologics Corporation, Bioventus LLC., RTI Surgical, Inc., Smith & Nephew PLC, Musculoskeletal Transplant Foundation, Seikagaku Corporation, AlloSource, Stryker Corporation, DePuy Synthes (a subsidiary of Johnson & Johnson Services, Inc.), Medtronic plc, Osiris Therapeutics, Inc., Kuros Biosciences AG, Globus Medical Inc., Wright Medical Group N.V, Arthrex, Inc., ISTO Technologies, Inc., CollPlant Ltd, OsteoMed and NuVasive, Inc.

Market Opportunities

The key opportunity for the players operating in orthobiologics market lies in the development of advanced reconstruction and repair products. Moreover, expanding distribution capabilities to explore and capture new marketplaces will facilitate a competitive edge for the major players in coming years. Increasing demand for patient specific therapy and rising incidence of spine related disorders will offer lucrative growth opportunities for the orthobiologics market in emerging countries during the next few years.

Orthobiologics Market Segmentation:

By Product:


Demineralized Bone Matrix (DBM)
Viscosupplementation
Bone Morphogenetic Protein (BMP)
Allograft
Stem Cell Therapy
Synthetic Bone Substitutes


By Application:


Trauma Repair
Spinal Fusion
Reconstructive Surgery


By End User:


Orthopedic Clinics
Hospitals


By Region:


North America



U.S
Canada
Mexico



Europe



Germany
France
UK
Italy
Spain
Rest of Europe



Asia-Pacific



Japan
China
Australia
India
South Korea
Rest of Asia Pacific



Rest of the World



Brazil
South Africa
Saudi Arabia
United Arab Emirates
Others


Some of the key questions answered by the report are:


What was the market size in 2016 and forecast from 2017 to 2025`
What will be the industry market growth from 2017 to 2025`
What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast`
What are the major segments leading the market growth and why`
Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition`

Table of Content

Table of Contents

1. Introduction

1.1. Report Description

1.2. Research Methodology

2. Executive Summary

2.1. Key Highlights

3. Market Overview

3.1. Introduction

3.1.1. Market Definition

3.1.2. Market Segmentation

3.2. Market Share Analysis

3.3. Market Dynamics

3.3.1. Drivers

3.3.1.1. Rising Geriatric Population

3.3.1.2. Rising Incidence of Sports Injuries

3.3.1.3. Increasing Demand for Minimally Invasive Surgical Procedures

3.3.1.4. Surge in the Number of Orthopedic Surgeries

3.3.2. Restraints

3.3.2.1. High Cost of Orthobiologics Related Surgeries

3.3.2.2. Stringent Regulatory Approval Process

3.3.3. Opportunities

3.3.3.1. Emerging Markets to Offer Lucrative Growth Opportunities

4. Orthobiologics Market, By Product

4.1. Introduction

4.2. Orthobiologics Market Assessment and Forecast, By Product, 2016-2025

4.3. Demineralized Bone Matrix

4.3.1. Market Assessment and Forecast, By Region, 2016-2025 ($Million)

4.4. Viscosupplementation

4.4.1. Market Assessment and Forecast, By Region, 2016-2025 ($Million)

4.5. Bone Morphogenetic Protein

4.5.1. Market Assessment and Forecast, By Region, 2016-2025 ($Million)

4.6. Allograft

4.6.1. Market Assessment and Forecast, By Region, 2016-2025 ($Million)

4.7. Stem Cell Therapy

4.7.1. Market Assessment and Forecast, By Region, 2016-2025 ($Million)

4.8. Synthetic Bone Substitutes

4.8.1. Market Assessment and Forecast, By Region, 2016-2025 ($Million)

5. Orthobiologics Market, By Application

5.1. Introduction

5.2. Orthobiologics Market Assessment and Forecast, By Application, 2016-2025

5.3. Trauma Repair

5.3.1. Market Assessment and Forecast, By Region, 2016-2025 ($Million)

5.4. Spinal Fusion

5.4.1. Market Assessment and Forecast, By Region, 2016-2025 ($Million)

5.5. Reconstructive Surgery

5.5.1. Market Assessment and Forecast, By Region, 2016-2025 ($Million)

6. Orthobiologics Market, By End User

6.1. Introduction

6.2. Orthobiologics Market Assessment and Forecast, By End User, 2016-2025

6.3. Orthopedic Clinics

6.3.1. Market Assessment and Forecast, By Region, 2016-2025 ($Million)

6.4. Hospitals

6.4.1. Market Assessment and Forecast, By Region, 2016-2025 ($Million)

7. Orthobiologics Market, By Region

7.1. Introduction

7.2. Orthobiologics Market Assessment and Forecast, By Region, 2016-2025 ($Million)

7.3. North America

7.3.1. Market Assessment and Forecast, By Country, 2016-2025 ($Million)

7.3.2. Market Assessment and Forecast, By Product, 2016-2025 ($Million)

7.3.3. Market Assessment and Forecast, By Application, 2016-2025 ($Million)

7.3.4. Market Assessment and Forecast, By End User, 2016-2025 ($Million)

7.3.4.1. U.S.

7.3.4.1.1. Market Assessment and Forecast, By Product, 2016-2025 ($Million)

7.3.4.1.2. Market Assessment and Forecast, By Application, 2016-2025 ($Million)

7.3.4.1.3. Market Assessment and Forecast, By End User, 2016-2025 ($Million)

7.3.4.2. Canada

7.3.4.2.1. Market Assessment and Forecast, By Product, 2016-2025 ($Million)

7.3.4.2.2. Market Assessment and Forecast, By Application, 2016-2025 ($Million)

7.3.4.2.3. Market Assessment and Forecast, By End User, 2016-2025 ($Million)

7.3.4.3. Mexico

7.3.4.3.1. Market Assessment and Forecast, By Product, 2016-2025 ($Million)

7.3.4.3.2. Market Assessment and Forecast, By Application, 2016-2025 ($Million)

7.3.4.3.3. Market Assessment and Forecast, By End User, 2016-2025 ($Million)

7.4. Europe

7.4.1. Market Assessment and Forecast, By Country, 2016-2025 ($Million)

7.4.2. Market Assessment and Forecast, By Product, 2016-2025 ($Million)

7.4.3. Market Assessment and Forecast, By Application, 2016-2025 ($Million)

7.4.4. Market Assessment and Forecast, By End User, 2016-2025 ($Million)

7.4.4.1. Germany

7.4.4.1.1. Market Assessment and Forecast, By Product, 2016-2025 ($Million)

7.4.4.1.2. Market Assessment and Forecast, By Application, 2016-2025 ($Million)

7.4.4.1.3. Market Assessment and Forecast, By End User, 2016-2025 ($Million)

7.4.4.2. France

7.4.4.2.1. Market Assessment and Forecast, By Product, 2016-2025 ($Million)

7.4.4.2.2. Market Assessment and Forecast, By Application, 2016-2025 ($Million)

7.4.4.2.3. Market Assessment and Forecast, By End User, 2016-2025 ($Million)

7.4.4.3. UK

7.4.4.3.1. Market Assessment and Forecast, By Product, 2016-2025 ($Million)

7.4.4.3.2. Market Assessment and Forecast, By Application, 2016-2025 ($Million)

7.4.4.3.3. Market Assessment and Forecast, By End User, 2016-2025 ($Million)

7.4.4.4. Italy

7.4.4.4.1. Market Assessment and Forecast, By Product, 2016-2025 ($Million)

7.4.4.4.2. Market Assessment and Forecast, By Application, 2016-2025 ($Million)

7.4.4.4.3. Market Assessment and Forecast, By End User, 2016-2025 ($Million)

7.4.4.5. Spain

7.4.4.5.1. Market Assessment and Forecast, By Product, 2016-2025 ($Million)

7.4.4.5.2. Assessment and Forecast, By Application, 2016-2025 ($Million)

7.4.4.5.3. Market Assessment and Forecast, By End User, 2016-2025 ($Million)

7.4.4.6. Russia

7.4.4.6.1. Market Assessment and Forecast, By Product, 2016-2025 ($Million)

7.4.4.6.2. Market Assessment and Forecast, By Application, 2016-2025 ($Million)

7.4.4.6.3. Market Assessment and Forecast, By End User, 2016-2025 ($Million)

7.4.4.7. Rest of Europe

7.4.4.7.1. Market Assessment and Forecast, By Product, 2016-2025 ($Million)

7.4.4.7.2. Assessment and Forecast, By Application, 2016-2025 ($Million)

7.4.4.7.3. Market Assessment and Forecast, By End User, 2016-2025 ($Million)

7.5. Asia-Pacific

7.5.1. Market Assessment and Forecast, By Country, 2016-2025 ($Million)

7.5.2. Market Assessment and Forecast, By Product, 2016-2025 ($Million)

7.5.3. Market Assessment and Forecast, By Application, 2016-2025 ($Million)

7.5.4. Market Assessment and Forecast, By End User, 2016-2025 ($Million)

7.5.4.1. Japan

7.5.4.1.1. Market Assessment and Forecast, By Product, 2016-2025 ($Million)

7.5.4.1.2. Market Assessment and Forecast, By Application, 2016-2025 ($Million)

7.5.4.1.3. Market Assessment and Forecast, By End User, 2016-2025 ($Million)

7.5.4.2. China

7.5.4.2.1. Market Assessment and Forecast, By Product, 2016-2025 ($Million)

7.5.4.2.2. Market Assessment and Forecast, By Application, 2016-2025 ($Million)

7.5.4.2.3. Market Assessment and Forecast, By End User, 2016-2025 ($Million)

7.5.4.3. Australia

7.5.4.3.1. Market Assessment and Forecast, By Product, 2016-2025 ($Million)

7.5.4.3.2. Market Assessment and Forecast, By Application, 2016-2025 ($Million)

7.5.4.3.3. Market Assessment and Forecast, By End User, 2016-2025 ($Million)

7.5.4.4. India

7.5.4.4.1. Market Assessment and Forecast, By Product, 2016-2025 ($Million)

7.5.4.4.2. Market Assessment and Forecast, By Application, 2016-2025 ($Million)

7.5.4.4.3. Market Assessment and Forecast, By End User, 2016-2025 ($Million)

7.5.4.5. South Korea

7.5.4.5.1. Market Assessment and Forecast, By Product, 2016-2025 ($Million)

7.5.4.5.2. Market Assessment and Forecast, By Application, 2016-2025 ($Million)

7.5.4.5.3. Market Assessment and Forecast, By End User, 2016-2025 ($Million)

7.5.4.6. Rest of Asia-Pacific

7.5.4.6.1. Market Assessment and Forecast, By Product, 2016-2025 ($Million)

7.5.4.6.2. Market Assessment and Forecast, By Application, 2016-2025 ($Million)

7.5.4.6.3. Market Assessment and Forecast, By End User, 2016-2025 ($Million)

7.6. Rest of the World

7.6.1. Market Assessment and Forecast, By Country, 2016-2025 ($Million)

7.6.2. Market Assessment and Forecast, By Product, 2016-2025 ($Million)

7.6.3. Market Assessment and Forecast, By Application, 2016-2025 ($Million)

7.6.4. Market Assessment and Forecast, By End User, 2016-2025 ($Million)

7.6.4.1. Brazil

7.6.4.1.1. Market Assessment and Forecast, By Product, 2016-2025 ($Million)

7.6.4.1.2. Market Assessment and Forecast, By Application, 2016-2025 ($Million)

7.6.4.1.3. Market Assessment and Forecast, By End User, 2016-2025 ($Million)

7.6.4.2. Turkey

7.6.4.2.1. Market Assessment and Forecast, By Product, 2016-2025 ($Million)

7.6.4.2.2. Market Assessment and Forecast, By Application, 2016-2025 ($Million)

7.6.4.2.3. Market Assessment and Forecast, By End User, 2016-2025 ($Million)

7.6.4.3. Saudi Arabia

7.6.4.3.1. Market Assessment and Forecast, By Product, 2016-2025 ($Million)

7.6.4.3.2. Market Assessment and Forecast, By Application, 2016-2025 ($Million)

7.6.4.3.3. Market Assessment and Forecast, By End User, 2016-2025 ($Million)

7.6.4.4. South Africa

7.6.4.4.1. Market Assessment and Forecast, By Product, 2016-2025 ($Million)

7.6.4.4.2. Market Assessment and Forecast, By Application, 2016-2025 ($Million)

7.6.4.4.3. Market Assessment and Forecast, By End User, 2016-2025 ($Million)

7.6.4.5. United Arab Emirates

7.6.4.5.1. Market Assessment and Forecast, By Product, 2016-2025 ($Million)

7.6.4.5.2. Market Assessment and Forecast, By Application, 2016-2025 ($Million)

7.6.4.5.3. Market Assessment and Forecast, By End User, 2016-2025 ($Million)

7.6.4.6. Others

7.6.4.6.1. Market Assessment and Forecast, By Product, 2016-2025 ($Million)

7.6.4.6.2. Market Assessment and Forecast, By Application, 2016-2025 ($Million)

7.6.4.6.3. Market Assessment and Forecast, By End User, 2016-2025 ($Million)

8. Company Profiles

8.1. Bone Biologics Corporation

8.1.1. Business Overview

8.1.2. Product Portfolio

8.1.3. Key Financials

8.1.4. Strategic Developments

8.2. Bioventus LLC.

8.2.1. Business Overview

8.2.2. Product Portfolio

8.2.3. Strategic Developments

8.3. RTI Surgical, Inc.

8.3.1. Business Overview

8.3.2. Product Portfolio

8.3.3. Key Financials

8.3.4. Strategic Developments

8.4. Smith & Nephew PLC

8.4.1. Business Overview

8.4.2. Product Portfolio

8.4.3. Key Financials

8.4.4. Strategic Developments

8.5. Stryker Corporation

8.5.1. Business Overview

8.5.2. Product Portfolio

8.5.3. Key Financials

8.5.4. Strategic Developments

8.6. Johnson & Johnson Services, Inc.

8.6.1. Business Overview

8.6.2. Product Portfolio

8.6.3. Key Financials

8.6.4. Strategic Developments

8.7. Medtronic plc

8.7.1. Business Overview

8.7.2. Product Portfolio

8.7.3. Key Financials

8.7.4. Strategic Developments

8.8. Osiris Therapeutics, Inc.

8.8.1. Business Overview

8.8.2. Product Portfolio

8.8.3. Key Financials

8.8.4. Strategic Developments

8.9. Globus Medical Inc.

8.9.1. Business Overview

8.9.2. Product Portfolio

8.9.3. Key Financials

8.9.4. Strategic Developments

8.10. Wright Medical Group N.V

8.10.1. Business Overview

8.10.2. Product Portfolio

8.10.3. Key Financials

8.10.4. Strategic Developments

8.11. NuVasive, Inc.

8.11.1. Business Overview

8.11.2. Product Portfolio

8.11.3. Key Financials

8.11.4. Strategic Developments

8.12. Arthrex, Inc.

8.12.1. Business Overview

8.12.2. Product Portfolio

8.12.3. Strategic Developments

8.13. Kuros Biosciences AG

8.13.1. Business Overview

8.13.2. Product Portfolio

8.13.3. Key Financials

8.13.4. Strategic Developments

8.14. ISTO Technologies, Inc.

8.14.1. Business Overview

8.14.2. Product Portfolio

8.14.3. Strategic Developments

8.15. CollPlant Ltd

8.15.1. Business Overview

8.15.2. Product Portfolio

8.15.3. Key Financials

8.15.4. Strategic Developments

8.16. OsteoMed

8.16.1. Business Overview

8.16.2. Product Portfolio

8.16.3. Strategic Developments

8.17. Musculoskeletal Transplant Foundation

8.17.1. Business Overview

8.17.2. Product Portfolio

8.17.3. Strategic Developments

8.18. Seikagaku Corporation

8.18.1. Business Overview

8.18.2. Product Portfolio

8.18.3. Key Financials

8.18.4. Strategic Developments

8.19. AlloSource

8.19.1. Business Overview

8.19.2. Product Portfolio

8.19.3. Strategic Developments


Table of Figures

Table 1.Orthobiologics Market, By Product, 2016-2025, ($Million)
Table 2.Demineralized Bone Matrix Market, By Region, 2016-2025, ($Million)
Table 3.Viscosupplementation Market, By Region, 2016-2025, ($Million),
Table 4.Bone Morphogenetic Protein Market, By Region, 2016-2025, ($Million)
Table 5.Allograft Market, By Region, 2016-2025, ($Million)
Table 6.Stem Cell Therapy Market, By Region, 2016-2025, ($Million)
Table 7.Synthetic Bone Substitutes Market, By Region, 2016-2025, ($Million)
Table 8.Orthobiologics Market, By Application, 2016-2025, ($Million)
Table 9.Trauma Repair Market, By Region, 2016-2025, ($Million)
Table 10.Spinal Fusion Market, By Region, 2016-2025, ($Million),
Table 11.Reconstructive Surgery Market, By Region ($Million), 2016-2025
Table 12.Orthobiologics Market, By End User, 2016-2025, ($Million)
Table 13.Orthopedic Clinics Market, By Region ($Million), 2016-2025
Table 14.Hospitals Market, By Region, 2016-2025, ($Million)
Table 15.Orthobiologics Market, By Region, 2016-2025 ($Million)
Table 16.North America Orthobiologics Market, By Country, 2016-2025 ($Million)
Table 17.North America Orthobiologics Market, By Product, 2016-2025 ($Million)
Table 18.North America Orthobiologics Market, By Application, 2016-2025 ($Million)
Table 19.North America Orthobiologics Market, By End User, 2016-2025 ($Million)
Table 20.U.S. Orthobiologics market, by Product, 2016-2025 ($Million)
Table 21.U.S. Orthobiologics market, by Application, 2016-2025 ($Million)
Table 22.U.S. Orthobiologics market, by End User, 2016-2025 ($Million)
Table 23.Canada Orthobiologics Market, By Product, 2016-2025 ($Million)
Table 24.Canada Orthobiologics Market, By Application, 2016-2025 ($Million)
Table 25.Canada Orthobiologics Market, By End User, 2016-2025 ($Million)
Table 26.Mexico Orthobiologics Market, By Product, 2016-2025 ($Million)
Table 27.Mexico Orthobiologics Market, By Application, 2016-2025 ($Million)
Table 28.Mexico Orthobiologics Market, By End User, 2016-2025 ($Million)
Table 29.Europe Orthobiologics Market, By Country, 2016-2025 ($Million)
Table 30.Europe Orthobiologics Market, By Product, 2016-2025 ($Million)
Table 31.Europe Orthobiologics Market, By Application, 2016-2025 ($Million)
Table 32.Europe Orthobiologics Market, By End User, 2016-2025 ($Million)
Table 33.Germany Orthobiologics Market, By Product, 2016-2025 ($Million)
Table 34.Germany Orthobiologics Market, By Application, 2016-2025 ($Million)
Table 35.Germany Orthobiologics Market, By End User, 2016-2025 ($Million)
Table 36.France Orthobiologics Market, By Product, 2016-2025 ($Million)
Table 37.France Orthobiologics Market, By Application, 2016-2025 ($Million)
Table 38.France Orthobiologics Market, By End User, 2016-2025 ($Million)
Table 39.UK Orthobiologics Market, By Product, 2016-2025 ($Million)
Table 40.UK Orthobiologics Market, By Application, 2016-2025 ($Million)
Table 41.UK Orthobiologics Market, By End User, 2016-2025 ($Million)
Table 42.Italy Orthobiologics Market, By Product, 2016-2025 ($Million)
Table 43.Italy Orthobiologics Market, By Application, 2016-2025 ($Million)
Table 44.Italy Orthobiologics Market, By End User, 2016-2025 ($Million)
Table 45.Spain Orthobiologics Market, By Product, 2016-2025 ($Million)
Table 46.Spain Orthobiologics Market, By Application, 2016-2025 ($Million)
Table 47.Spain Orthobiologics Market, By End User, 2016-2025 ($Million)
Table 48.Russia Orthobiologics Market, By Product, 2016-2025 ($Million)
Table 49.Russia Orthobiologics Market, By Application, 2016-2025 ($Million)
Table 50.Russia Orthobiologics Market, By End User, 2016-2025 ($Million)
Table 51.Rest of Europe Orthobiologics Market, By Product, 2016-2025 ($Million)
Table 52.Rest of Europe Orthobiologics Market, By Application, 2016-2025 ($Million)
Table 53.Rest of Europe Orthobiologics Market, By End User, 2016-2025 ($Million)
Table 54.Asia-Pacific Orthobiologics Market, By Country, 2016-2025 ($Million)
Table 55.Asia-Pacific Orthobiologics Market, By Product, 2016-2025 ($Million)
Table 56.Asia-Pacific Orthobiologics Market, By Application, 2016-2025 ($Million)
Table 57.Asia-Pacific Orthobiologics Market, By End User, 2016-2025 ($Million)
Table 58.Japan Orthobiologics Market, By Product, 2016-2025 ($Million)
Table 59.Japan Orthobiologics Market, By Application, 2016-2025 ($Million)
Table 60.Japan Orthobiologics Market, By End User, 2016-2025 ($Million)
Table 61.China Orthobiologics Market, By Product, 2016-2025 ($Million)
Table 62.China Orthobiologics Market, By Application, 2016-2025 ($Million)
Table 63.China Orthobiologics Market, By End User, 2016-2025 ($Million)
Table 64.Australia Orthobiologics Market, By Product, 2016-2025 ($Million)
Table 65.Australia Orthobiologics Market, By Application, 2016-2025 ($Million)
Table 66.Australia Orthobiologics Market, By End User, 2016-2025 ($Million)
Table 67.India Orthobiologics Market, By Product, 2016-2025 ($Million)
Table 68.India Orthobiologics Market, By Application, 2016-2025 ($Million)
Table 69.India Orthobiologics Market, By End User, 2016-2025 ($Million)
Table 70.South Korea Orthobiologics Market, By Product, 2016-2025 ($Million)
Table 71.South Korea Orthobiologics Market, By Application, 2016-2025 ($Million)
Table 72.South Korea Orthobiologics Market, By End User, 2016-2025 ($Million)
Table 73.Rest of Asia-Pacific Orthobiologics Market, By Product, 2016-2025 ($Million)
Table 74.Rest of Asia-Pacific Orthobiologics Market, By Application, 2016-2025 ($Million)
Table 75.Rest of Asia-Pacific Orthobiologics Market, By End User, 2016-2025 ($Million)
Table 76.Rest of the World Orthobiologics Market, By Country, 2016-2025 ($Million)
Table 77.Rest of the World Orthobiologics Market, By Product, 2016-2025 ($Million)
Table 78.Rest of the World Orthobiologics Market, By Application, 2016-2025 ($Million)
Table 79.Rest of the World Orthobiologics Market, By End User, 2016-2025 ($Million)
Table 80.Brazil Orthobiologics Market, By Product, 2016-2025 ($Million)
Table 81.Brazil Orthobiologics Market, By Application, 2016-2025 ($Million)
Table 82.Brazil Orthobiologics Market, By End User, 2016-2025 ($Million)
Table 83.Turkey Orthobiologics Market, By Product, 2016-2025 ($Million)
Table 84.Turkey Orthobiologics Market, By Application, 2016-2025 ($Million)
Table 85.Turkey Orthobiologics Market, By End User, 2016-2025 ($Million)
Table 86.Saudi Arabia Orthobiologics Market, By Product, 2016-2025 ($Million)
Table 87.Saudi Arabia Orthobiologics Market, By Application, 2016-2025 ($Million)
Table 88.Saudi Arabia Orthobiologics Market, By End User, 2016-2025 ($Million)
Table 89.South Africa Orthobiologics Market, By Product, 2016-2025 ($Million)
Table 90.South Africa Orthobiologics Market, By Application, 2016-2025 ($Million)
Table 91.South Africa Orthobiologics Market, By End User, 2016-2025 ($Million)
Table 92.United Arab Emirates Orthobiologics Market, By Product, 2016-2025 ($Million)
Table 93.United Arab Emirates Orthobiologics Market, By Application, 2016-2025 ($Million)
Table 94.United Arab Emirates Orthobiologics Market, By End User, 2016-2025 ($Million)
Table 95.Others Orthobiologics Market, By Product, 2016-2025 ($Million)
Table 96.Others Orthobiologics Market, By Application, 2016-2025 ($Million)
Table 97.Others Orthobiologics Market, By End User, 2016-2025 ($Million)
Table 98.Bone Biologics Corporation: Key Strategic Developments, 2015-2017
Table 99.Bioventus LLC.: Key Strategic Developments, 2015-2017
Table 100.RTI Surgical, Inc.: Key Strategic Developments, 2015-2017
Table 101.Smith & Nephew PLC: Key Strategic Developments, 2015-2017
Table 102.DePuy Synthes: Key Strategic Developments, 2015-2017
Table 103.Medtronic plc: Key Strategic Developments, 2015-2017
Table 104.Osiris Therapeutics, Inc.: Key Strategic Developments, 2015-2017
Table 105.Globus Medical Inc.: Key Strategic Developments, 2015-2017
Table 106.Wright Medical Group N.V: Key Strategic Developments, 2015-2017
Table 107.NuVasive, Inc.: Key Strategic Developments, 2015-2017
Table 108.Stryker Corporation: Key Strategic Developments, 2015-2017
Table 109.Arthrex, Inc.: Key Strategic Developments, 2015-2017
Table 110.ISTO Technologies, Inc.: Key Strategic Developments, 2015-2017
Table 111.CollPlant Ltd: Key Strategic Developments, 2015-2017
Table 112.Kuros Biosciences AG: Key Strategic Developments, 2015-2017
Table 113.OsteoMed: Key Strategic Developments, 2015-2017

Request Sample

* mark fields are compulsory